Search
On 14th December, we shall be changing over completely to the new version of Value Research Online. You can try it out here: https://beta.valueresearchonline.com

Astrazeneca Pharma India

Sector: Healthcare | Industry: Drugs & Pharma
R 2,756.55 80.85  | 3.02% 99.97% 92.09 6,892.63
NSE Price: Dec 12, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Dec 12, 15:59 2,756.55 80.85 3.02% 2,690.00 2,675.70 14,765 2,661.30 - 2,775.00
BSE Dec 12, 2019 2,757.05 80.35 3.00% 2,661.30 2,676.70 1,461 2,661.30 - 2,774.40
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 24,911 P/B: 20.91 NSE Code: ASTRAZEN
52-Week Range: R 1,376.00 - 2,865.90 Dividend Yield: 0.00% BSE Code: 506820
TTM EPS: R 29.94 Book Value: R 131.83 Face Value: R 2
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Procter & Gamble Health (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Our equity analyst team has sifted through hundreds of companies and selected a short list of stocks that you should invest in.
This list now has 37 stocks on it. Thousands of our members are using stagnant equity markets to buy great stocks at low prices.

Membership is currently available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Astrazeneca Pharma India 89.90 8.45 34.74 99.97 42.62 27.17 11.34
S&P BSE Small Cap -10.08 -2.03 2.45 -8.19 2.64 3.62 5.19
S&P BSE Healthcare -3.99 1.85 2.27 -3.32 -4.76 -2.21 10.48
Company's return has been calculated on basis of NSE's price.
As on Dec 12, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 27.55 8.91 8.97
Net Profit 110.15 117.95 155.55
EPS 110.15 117.95 155.54
Book Value 21.99 24.17 11.72
Average
Operating Margin 12.03 10.57 6.95
Net Margin 7.31 5.12 2.46
Return on Networth 20.03 13.93 6.46
Return on Investment 26.53 21.31 10.95
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 1.92 29.20 9.55
Operating Profit -4.75 102.67 196.57
Net Profit -33.00 57.83 46.73
EPS -33.00 57.83 46.73
TTM
Revenue 6.11 35.96 12.39
Operating Profit 16.40 227.27 50.76
Net Profit 7.59 791.55 37.48
EPS 7.59 791.55 37.48
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Astrazeneca Pharma India 6,892.63 818.54 74.85 8.97 20.03 20.91 92.09
Eris Lifesciences 6,357.54 1,026.31 310.85 29.43 28.96 4.80 20.44
Procter & Gamble Health 6,860.44 894.23 835.89 14.21 73.79 8.80 51.19
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
May 28, 2013 AstraZeneca Pharmaceuticals AB Sweden  Sell - 3,749,950 668.60 25,072.17
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
ICICI Prudential Mutual Fund 1.909 2.523 3.095 4.186 4.312
Nippon India Mutual Fund 1.131 1.131 1.131 1.131 1.131
IDBI Mutual Fund 0.009 0.004 - - -
Motilal Oswal Mutual Fund 0.001 - - - -
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Astrazeneca Pharma India Ltd.

Address: Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Outer Ring Road, Bengaluru, Karnataka - 560045

Email: [email protected]

Website: www.astrazenecaindia.com

Registrar & Transfer Agent: Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)

Address: 30, Ramana Residency, 4th Cross, Sampige Road, Malleswaram, Bangalore 560003, 30, Ramana Residency, 4th Cross, Sampige Road, Malleswaram | Phone: 91-080-23460815 to 818 | Fax: 91-080 23460819

Email: [email protected], [email protected]

Essential checks
Altman Z-Score
16.09
Piotroski F-Score
9
Modified C-Score
2
5-Years Price to Earnings
92.09
5-Years Price to Book
20.91
Earnings Yield
EBIT / Enterprise value
1.71%
PEG
Price / Earnings to growth ratio
3.15
Related Stocks
  Current Price   Chng %
Eris Lifesciences R461.85 -1.27%
FDC R204.35 +0.69%
Granules India R129.50 +3.60%
JB Chemicals & Pharma R415.15 -0.86%
Laurus Labs R338.25 +1.14%
Procter & Gamble Health R4,138.65 +0.18%
Strides Pharma Science R367.75 +2.25%
Sun Pharma Adv. Research R163.10 +0.03%
Suven Life Sciences R272.40 +0.65%
Wockhardt R240.60 +0.56%
As on Dec 12, 15:59